Sarina Elmariah is a Dermatology physician affiliated with University of California, San Francisco. OpenAlex indexes 82 publications with 1,962 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1701 Divisadero
San Francisco, CA 941152621
Telephone
415-353-7800Provider last certified this registry record 10 May 2023.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year202527 payments$103,017openpaymentsdata.cms.gov ↗
- Galderma Laboratories, L.P.Program year202514 payments$67,286openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year202526 payments$34,107openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
29.9%Gabapentinoids21.9%Pregabalin56%Gabapentin44%Part D≥23 patientsTricyclic Antidepressant6.7%Nortriptyline Hcl51%Doxepin Hcl49%Part D<11 patients+ 1 more class in this area
Cancer & immunology
17.3%Calcineurin inhibitor6.1%Tacrolimus100%Part D≥22 patientsFolate Analog Metabolic Inhibitor5.8%Methotrexate100%Part D≥11 patients+ 3 more classes in this area
Dermatology
17.2%Interleukin-4 Receptor alpha Antagonist8.9%Dupixent Pen100%Part D≥12 patientsCorticosteroid5.6%Triamcinolone Acetonide100%Part D≥31 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies
Journal of the European Academy of Dermatology and Venereology
2025 - The <scp>SWITCH</scp> algorithm: An expert consensus on treat‐to‐target criteria for chronic prurigo
Journal of the European Academy of Dermatology and Venereology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”